Kymera Therapeutics (KYMR) PT Raised to $67 at Oppenheimer
Tweet Send to a Friend
(Updated - November 4, 2025 1:19 PM EST)
Oppenheimer analyst Jeff Jones raised the price target on Kymera Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Oppenheimer analyst Jeff Jones raised the price target on Kymera Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
